Visacor

Quốc gia: New Zealand

Ngôn ngữ: Tiếng Anh

Nguồn: Medsafe (Medicines Safety Authority)

Thành phần hoạt chất:

Rosuvastatin calcium 41.6mg equivalent to 40 mg rosuvastatin;  

Sẵn có từ:

AstraZeneca Limited

INN (Tên quốc tế):

Rosuvastatin calcium 41.6 mg (= 40 mg rosuvastatin)

Liều dùng:

40 mg

Dạng dược phẩm:

Film coated tablet

Thành phần:

Active: Rosuvastatin calcium 41.6mg equivalent to 40 mg rosuvastatin   Excipient: Calcium phosphate Crospovidone Hypromellose as Opadry Pink Iron oxide red as Opadry Pink Lactose monohydrate as Opadry Pink   Magnesium stearate Microcrystalline cellulose Titanium dioxide as Opadry Pink Triacetin as Opadry Pink

Các đơn vị trong gói:

Blister pack, Al/Al foil, 30 tablets

Lớp học:

Prescription

Loại thuốc theo toa:

Prescription

Sản xuất bởi:

AstraZeneca UK Ltd

Chỉ dẫn điều trị:

VISACOR is indicated to: - Reduce elevated LDL-C, Total Cholesterol, triglycerides and to increase HDLcholesterol in patients with primary hypercholesterolemia (heterozygous familial and non familial) and mixed dyslipidaemia (Fredrickson Types IIa and IIb). - Treat isolated hypertriglyceridaemia (Fredrickson Type IV hyperlipidaemia). Reduce Total Cholesterol and LDL-C in patients with homozygous familial hypercholesterolemia, as an adjunct to diet and other lipid lowering treatments (eg. LDL apheresis) or alone if such treatments are unavailable.

Tóm tắt sản phẩm:

Package - Contents - Shelf Life: Blister pack, Al/Al foil - 30 tablets - 36 months from date of manufacture stored at or below 30°C

Ngày ủy quyền:

2009-07-31